Semaglutide was associated with long-term, per-person cost savings of DKK 6,068 in the full population and DKK 9,212 in those not receiving SGLT-2 inhibitors at baseline, leading to semaglutide being a dominant treatment compared with placebo
Eli Lilly and Novo Nordisk have the strongest large-cap pipelines
At TrimRx, we offer personalized weight loss programs, prescription medications, and comprehensive support to ensure your journey is safe, effective, and tailored to your unique needs
Always inform your pharmacist or healthcare professional of prescription drugs, over-the-counter meds and supplements you take, to avoid drug interactions
Liu D, Liang C-H, Huang B, Zhuang X, Cui W, Yang L, et al